from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3284/-

LFCtreatmentdescriptionclass of inhibitor

-2.585

Amikacinug/mL Amikacintranslation

-2.008

Cap5-10ug/mL Capreomycintranslation

-2.492

Rox10-50 ug/mL Roxithromycintranslation

0.204

SM2-5 ug/mL Streptomycintranslation

-2.029

Tet5-10 ug/mL Tetracyclinetranslation

-0.999

Rif0.2-5ug/mL Rifampicintranscription

-0.996

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.948

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.308

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.927

CPZ10-50 ug/mL Chlorpromazinerespiration

1.688

Clofazimine10-13 ug/mL Clofaziminerespiration

0.593

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.421

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.810

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.196

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.824

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.582

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.949

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.886

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.778

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

1.513

KCN5-20 ug/mL Potassium cyaniderespiration

0.613

NaN30.2-2 mM Sodium aziderespiration

0.972

Nigericin50 uM Nigericinrespiration

-0.483

TRC10-150 ug/mL Triclosanrespiration

-0.611

TRZ10-25 ug/mL Thioridazinerespiration

-2.079

Valinomycin0.5-10 uM Valinomycinrespiration

0.561

ZnSO42 mM ZnSO4respiration

0.733

menadione6-10 ug/mL Menadionerespiration

0.455

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.343

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.089

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.492

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.252

NRP_1Non-replicating persistence stage 1dosRassociated

0.801

Amp0.2mg/mL AmpicillincellWall

0.052

Cephalexin20-100 ug/mL CephalexincellWall

0.719

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.079

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.433

EMB10-20 ug/mL EthambutolcellWall

0.913

Eta12-40 ug/mL EthionamidecellWall

1.164

INH0.2-0.4 ug/mL IsoniazidcellWall

0.543

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.707

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.075

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.551

BZA0.12 mg/mL BenzamidearomaticAmides

-0.904

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.831

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.634

H2O24 mM hydrogen peroxideDNAdamaging

-0.278

Levo10 ug/mL LevofloxacinDNAdamaging

0.005

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.142

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.319

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.119

UVUV-irradiationDNAdamaging

-0.413

ARP41-4 ug/mL Antitubercular compound ARP4?

0.160

Antimycin12.5-50 ug/mL Antimycin A?

0.305

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.396

PA_110-50 ug/mL Antitubercular compound PA-1?

0.257

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.398

PA8240.2-2 ug/mL PA-824?

0.912

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.560

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.644

Verapamil50 uM Verapamil?

0.399

mercaptoethanol2 mM 2-Mercaptoethanol?

0.368

methoxatin10-20 ug/mL Methoxatin?